BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36417488)

  • 41. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
    Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
    World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
    Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple-level copy number variations in cell-free DNA for prognostic prediction of HCC with radical treatments.
    Wang Y; Zhou K; Wang X; Liu Y; Guo D; Bian Z; Su L; Liu K; Gu X; Guo X; Wang L; Zhang H; Tao K; Xing J
    Cancer Sci; 2021 Nov; 112(11):4772-4784. PubMed ID: 34490703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detecting Liver Cancer Using Cell-Free DNA Fragmentomes.
    Foda ZH; Annapragada AV; Boyapati K; Bruhm DC; Vulpescu NA; Medina JE; Mathios D; Cristiano S; Niknafs N; Luu HT; Goggins MG; Anders RA; Sun J; Meta SH; Thomas DL; Kirk GD; Adleff V; Phallen J; Scharpf RB; Kim AK; Velculescu VE
    Cancer Discov; 2023 Mar; 13(3):616-631. PubMed ID: 36399356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR.
    Wang J; Yang L; Diao Y; Liu J; Li J; Li R; Zheng L; Zhang K; Ma Y; Hao X
    J Int Med Res; 2021 Mar; 49(3):300060521992962. PubMed ID: 33750234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating Tumor DNA and Hepatocellular Carcinoma.
    Yang JD; Liu MC; Kisiel JB
    Semin Liver Dis; 2019 Nov; 39(4):452-462. PubMed ID: 31226727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.
    Chen K; Zhang H; Zhang LN; Ju SQ; Qi J; Huang DF; Li F; Wei Q; Zhang J
    World J Gastroenterol; 2013 May; 19(20):3143-9. PubMed ID: 23716996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial.
    Alunni-Fabbroni M; Rönsch K; Huber T; Cyran CC; Seidensticker M; Mayerle J; Pech M; Basu B; Verslype C; Benckert J; Malfertheiner P; Ricke J
    J Transl Med; 2019 Oct; 17(1):328. PubMed ID: 31570105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. eVIDENCE: a practical variant filtering for low-frequency variants detection in cell-free DNA.
    Mizuno K; Akamatsu S; Sumiyoshi T; Wong JH; Fujita M; Maejima K; Nakano K; Ono A; Aikata H; Ueno M; Hayami S; Yamaue H; Chayama K; Inoue T; Ogawa O; Nakagawa H; Fujimoto A
    Sci Rep; 2019 Oct; 9(1):15017. PubMed ID: 31641155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.
    Coto-Llerena M; Benjak A; Gallon J; Meier MA; Boldanova T; Terracciano LM; Ng CKY; Piscuoglio S
    JCO Precis Oncol; 2022 Mar; 6():e2100335. PubMed ID: 35263170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma.
    Youssef SS; El-Araby RE; Abbas EAE; Hassany M; Elbaz T
    Expert Rev Mol Diagn; 2023 Mar; 23(3):267-278. PubMed ID: 36803362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
    Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
    Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
    Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.
    Han LY; Fan YC; Mu NN; Gao S; Li F; Ji XF; Dou CY; Wang K
    Int J Med Sci; 2014; 11(2):164-71. PubMed ID: 24465162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of TERT promoter mutation in serum cell-free DNA using wild-type blocking PCR combined with Sanger sequencing in hepatocellular carcinoma.
    Akuta N; Suzuki F; Kobayashi M; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Suzuki Y; Kumada H
    J Med Virol; 2020 Dec; 92(12):3604-3608. PubMed ID: 32100879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Bai Y; Tong W; Xie F; Zhu L; Wu H; Shi R; Wang L; Yang L; Liu Z; Miao F; Zhao Q; Zhang Y
    Aging (Albany NY); 2021 Jul; 13(13):17592-17606. PubMed ID: 34237708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prognostic value of postoperative circulating cell-free DNA in operable hepatocellular carcinoma.
    Long G; Fang T; Su W; Mi X; Zhou L
    Scand J Gastroenterol; 2020 Dec; 55(12):1441-1446. PubMed ID: 33119422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
    Park S; Lee EJ; Rim CH; Seong J
    Yonsei Med J; 2018 Jun; 59(4):470-479. PubMed ID: 29749129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.